Histone deacetylases and the immunological network: implications in cancer and inflammation
出版年份 2009 全文链接
标题
Histone deacetylases and the immunological network: implications in cancer and inflammation
作者
关键词
-
出版物
ONCOGENE
Volume 29, Issue 2, Pages 157-173
出版商
Springer Nature
发表日期
2009-10-26
DOI
10.1038/onc.2009.334
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- T-Bet Dependent Removal of Sin3A-Histone Deacetylase Complexes at the Ifng Locus Drives Th1 Differentiation
- (2014) S. Chang et al. JOURNAL OF IMMUNOLOGY
- Histone Acetylation and Flagellin Are Essential for Legionella pneumophila-Induced Cytokine Expression
- (2014) B. Schmeck et al. JOURNAL OF IMMUNOLOGY
- Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2
- (2009) Grace O. Osoata et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- HDAC3 influences phosphorylation of STAT3 at serine 727 by interacting with PP2A
- (2009) Sumihito Togi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis
- (2009) Cai Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
- (2009) Ailsa J. Frew et al. CANCER LETTERS
- Development of the pan-DAC inhibitor panobinostat (LBH589): Successes and challenges
- (2009) Peter Atadja CANCER LETTERS
- When Sirtuins and NF-κB Collide
- (2009) Gioacchino Natoli CELL
- The Changing Face of HDAC Inhibitor Depsipeptide
- (2009) Wen Zhou et al. CURRENT CANCER DRUG TARGETS
- miRNA regulation of cytokine genes
- (2009) Ananthi J. Asirvatham et al. CYTOKINE
- Belinostat: a new broad acting antineoplastic histone deacetylase inhibitor
- (2009) Peter Gimsing EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A phosphorylation-acetylation switch regulates STAT1 signaling
- (2009) O. H. Kramer et al. GENES & DEVELOPMENT
- Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas
- (2009) Lena Marquard et al. HISTOPATHOLOGY
- The transcription repressor, ZEB1, cooperates with CtBP2 and HDAC1 to suppress IL-2 gene activation in T cells
- (2009) J. Wang et al. INTERNATIONAL IMMUNOLOGY
- Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines
- (2009) Ingo Hartlapp et al. LEUKEMIA RESEARCH
- Recent progress in the biology and physiology of sirtuins
- (2009) Toren Finkel et al. NATURE
- High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas
- (2008) Mehdi Ouaïssi et al. ANNALS OF SURGICAL ONCOLOGY
- SIRT1 longevity factor suppresses NF-κB -driven immune responses: regulation of aging via NF-κB acetylation?
- (2008) Antero Salminen et al. BIOESSAYS
- Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas
- (2008) Agda KB Lucio-Eterovic et al. BMC CANCER
- Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer
- (2008) Florian R Fritzsche et al. BMC CANCER
- Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
- (2008) W Weichert et al. BRITISH JOURNAL OF CANCER
- Molecular mechanisms of MHC class I abnormalities and APM components in human tumors
- (2008) Barbara Seliger CANCER IMMUNOLOGY IMMUNOTHERAPY
- Valproic acid as epigenetic cancer drug: Preclinical, clinical and transcriptional effects on solid tumors
- (2008) Alfonso Duenas-Gonzalez et al. CANCER TREATMENT REVIEWS
- Control of cytokine gene transcription in Th1 and Th2 cells
- (2008) H. Bowen et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Evaluation of the Pharmacodynamic Effects of MGCD0103 from Preclinical Models to Human Using a Novel HDAC Enzyme Assay
- (2008) C. Bonfils et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase 8 in Neuroblastoma Tumorigenesis
- (2008) I. Oehme et al. CLINICAL CANCER RESEARCH
- A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
- (2008) Peter Gimsing et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Promising antitumor activity with MGCD0103, a novel isotype-selective histone deacetylase inhibitor
- (2008) Christophe Le Tourneau et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Histone deacetylase inhibitors in lymphoma and solid malignancies
- (2008) Walid Rasheed et al. Expert Review of Anticancer Therapy
- Selective repression of YKL-40 by NF-κB in glioma cell lines involves recruitment of histone deacetylase-1 and -2
- (2008) Krishna P. Bhat et al. FEBS LETTERS
- Contextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10
- (2008) Ming O. Li et al. IMMUNITY
- Epigenetics and T helper 1 differentiation
- (2008) Thomas M. Aune et al. IMMUNOLOGY
- Rapid histone deacetylation and transient HDAC association in the IL-2 promoter region of TSST-1-stimulated T cells
- (2008) Yoshie Kametani et al. IMMUNOLOGY LETTERS
- The role of histone deacetylases in asthma and allergic diseases
- (2008) Pankaj Bhavsar et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Caspase-8 Cleaves Histone Deacetylase 7 and Abolishes Its Transcription Repressor Function
- (2008) Fiona L. Scott et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells
- (2008) C Nishioka et al. LEUKEMIA
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance
- (2008) Alejandro Villagra et al. NATURE IMMUNOLOGY
- Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
- (2008) Aleksey G. Kazantsev et al. NATURE REVIEWS DRUG DISCOVERY
- The many roles of histone deacetylases in development and physiology: implications for disease and therapy
- (2008) Michael Haberland et al. NATURE REVIEWS GENETICS
- The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
- (2008) Xiang-Jiao Yang et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- HDAC6: a key regulator of cytoskeleton, cell migration and cell–cell interactions
- (2008) Agustín Valenzuela-Fernández et al. TRENDS IN CELL BIOLOGY
- Histone Deacetylation
- (2008) Anas Al-Janadi et al. Drugs in research & development
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started